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Methods: Three hundred forty-two patients with lung cancer and 99 patients 
with nonneoplastic lung diseases (control group) underwent intraoperative 
pleural lavage with 300 ml physiologic saline solution before (lavage I) and 
after resection (lavage II). Results: Studies of the lavage fluid in all control 
patients were negative, that is, there were no false positive findings. Tumor 
cells were found in lavage I in 132 patients (38.6%) and also in lavage II in 
99 of them. In stage I (pT1 NO, pT2 NO) lung cancer, tumor cell detection 
was possible in 47 patients (28.6%). The 4-year survival of patients with 
resected non-small-cell lung cancer was 24% (95% confidence interval, 16% 
to 32%) if lavage I results were positive and 52% (95% confidence interval, 
45% to 59%) if lavage I results were negative (all stages, p = 0.007). For 
patients with stage I disease (n = 164) the 4-year survival was 35% (95% 
confidence interval, 18% to 52%) if lavage I results were positive (n = 47), 
and 69% (95% confidence interval, 60% to 78%) if lavage I results were 
negative (n = 117) (p = 0.037). On multivariate analysis the positive 
cytologic result in intraoperative pleural lavage was an additional prognos- 
tic factor for our patients. To prove how the tumor cells enter the pleura! 
cavity, we performed tissue cultures of tumor-free parenchyma in 23 cases 
of lung cancer. Tumor cell detection by histology and immunohistology was 
possible in 16 cases (69.6%). Detection of tumor cells in pleural lavage fluid 
before resection proves that tumor cells have spread into the pleural cavity. 
Conclusion: The positive result in pleural lavage seems to be a prognostic 
predictor for patients with lung cancer. (J Thorac Cardiovasc Surg 1997; 
113:683-90) 
I n 1958 Spjut and associates ~ reported the results of pleural cavity washings on 49 patients undergoing 
thoracotomy for lung cancer. They presented the 
cytologic examination of pleural lavage. In 16 of 
their patients (32.7%) the cytologic result was pos- 
itive for malignant cells. In 1984 Eagan and col- 
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leagues 2 followed with their results with pleural 
lavage cytology after pulmonary resection for lung 
cancer. The cytologic results of lavage were positive 
for malignant cells in 12 of their 135 patients (8.9%). 
In both studies intraoperative pleural lavage was 
performed only after pulmonary resection for lung 
cancer, and neither study considered its prognostic 
value. 
In 1989 Kondo and coworkers 3 reported on the 
prognostic factor of positive cytologic results in 
pleural lavage immediately after thoracotomy for 
patients with lung cancer. At the same time, we 4 
published our first preliminary report about the 
positive cytologic results in intraoperative pleural 
lavage after opening the chest and before resection. 
At that time we found a significantly poorer 2-year 
survival for patients with positive findings in pleural 
lavage. 
Now we present the results of our advanced 
prospective study about intraoperative pleural la- 
vage in lung cancer. To find out how the tumor cells 
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Table I. Characteristics of the patients, 
operations, histologic type, and final tumor stage 
of the patients undergoing intraoperative pleural 
lavage (n = 342) 
No. % 
Sex 
Male 294 86 
Female 48 14 
Operations 
Pneumonectomies 109 31.9 
Bilobectomies 27 7.9 
Lobectomies 185 54.1 
Wedge resections 15 4.4 
Exploratory. thoracotomies 6 1.7 
Postoperative tumor stage 
Stage I 164 47.9 
Stage II 55 16.1 
Stage IIIA 75 21.9 
Stage IIIB 25 7.3 
Stage IV 23 6.7 
Histologic type 
Squamous cell carcinomas 189 55.3 
Adenocarcinomas 102 29.8 
Adenosquamous carcinomas 22 6.4 
Large-cell carcinomas 17 5 
Small-cell carcinomas 12 3.5 
enter pleural cavity before pulmonary resection, we 
performed lung tissue cultures of the surrounding 
tumor-free lung parenchyma. 
Patients and methods 
Intraoperative pleural lavage. From January 1986 to 
December 1987 and from January 1990 to December 
1995, 484 patients underwent resection for primary lung 
cancer at the Department of General and Thoracic Sur- 
gery of the Justus Liebig University at Giessen. Intraop- 
erative pleural lavage was performed in 342 patients 
(study group) with the first manifestation of lung cancer 
(294 men and 48 women, average age 58.9 years). We 
performed pleural avage in the time from January 1986 to 
December 1987 as a experimental evaluation. After ob- 
taining our results with the significantly poorer 2-year 
survival for those patients with a positive result of intra- 
operative pleural lavage, 4 we continued our study in 
January 1990. Patients who had previously received che- 
motherapy or radiotherapy and patients with a malignant 
secondary tumor were excluded. Preoperative valuation 
included a detailed history and physical examination, 
biochemical profile, chest x-ray examination, bronchos- 
copy, computed tomography of the chest and upper 
portion of the abdomen, and abdominal ultrasonographie 
scan. Neither preoperative computed tomographic s an of 
the brain nor routine cervical or anterior mediastinoscopy 
was performed in the absence of clinical evidence of brain 
involvement and in the presence of a negative mediastinal 
window shown by tomographic examination, respectively. 
None of the patients had an intraoperative pteural effu- 
sion. Intraoperative pleural avage was performed in every 
possible case as described herein and without patient 
consent, because this examination did not influence our 
intraoperative procedures and postoperative manage- 
ment. 
The control group comprised 99 patients with nodules 
of the lung, which on postoperative histologic examination 
were not malignant. In both groups we performed intra- 
operative pleural avage in the same manner. 
After an anterolateral thoracotomy, the pleural cavity 
was filled with 300 ml physiologic saline solution before 
any further manipulation of the pulmonary parenchyma. 
To obtain only desquamated cells, we avoided touching 
the pleural surfaces. The surgeon carefully washed the 
pleural cavity by hand for 1 minute. The fluid was then 
suctioned off, and 1000 units of heparin and 50 ml of 
Ebner's solution 4' 5 were added (lavage I). After surgical 
resection of the tumor and lymph node dissection, the 
washing was repeated in the same manner (lavage II). 
Immediately after the lavages, the fluid was shaken, and 
12 cytocentrifugates of 2 ml each (24 ml) were prepared 
and stained according to the Papanicolaou method. From 
the remaining lavage fluid, the sediment was separated by 
centrifugation. After erythrocytolysis with acetic acid and 
fixation in alcohol, the sediments were embedded in 
paraffin, completely serial-sectioned, and stained with 
hematoxylin and eosin. Microscopic examination was 
performed by two physicians (J.B., K.H.B.) and their 
findings reported according to Papanicolaou's classifi- 
cation. The results of the cytologic examination were 
divided into two categories: "negative lavage" and 
"positive lavage." Papanicolaou classes I to III were 
declared as "negative lavage" and Papanicolaou classes 
IV to V as "positive lavage." 
The primary tumor and lymph node status was clas- 
sified according to the international staging system 
reported by Mountain. 6 Careful intraoperative staging 
at the time of surgical resection was done by dissecting 
intrapulmonary and hilar nodes and sampling medias- 
tinal lymph node stations. The histologic type of the 
tumor was determined by applying the World Health 
organization classification] The results of the his- 
topathologic examination regarding the status of lymph 
node metastasis and pleural involvement by the tumor 
were documented. 8 
The X 2 test was used to evaluate the significance of the 
relationship between the cytologic result of intraoperative 
pleural lavage and the histopathologic findings. Survival 
curves were calculated according to the method of Kaplan 
and Meier, 9 and the log-rank test was used to compare the 
survival curves] ° Perioperative mortality (17/342, 4.9%) 
was included in the calculation of the survival. The 
survival was calculated without censored data, and pa- 
tients who died with no evidence of recurrence and with 
an unrelated disease were not excluded. Cox's propor- 
tional hazards stepwise model was used for multivariate 
analysis. 11 For all calculations we used the program SPSS 
(Statistical Package for the Social Sciences) for Windows 
(SPSS, Inc, Chicago, Ill.). 
Lung tissue cultures. To clarify how the tumor cells 
enter the pleural space, we performed tissue cultures of 
tumor-free lung parenchyma surrounding the lung cancer. 
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Fig. 1. A malignant cell in intraoperative pleural avage fluid (lavage I) of a squamous cell carcinoma (pT2 
NO, stage I, G2; Papanicolaou staining; original magnification ×500). 
Fig. 2. Malignant cells in the sediment of intraoperative pleural avage (lavage I, arrows) (adenocarcino- 
ma, pT2 NO, stage I, G2-3; hematoxylin and eosin staining, original magnification ×500). 
In 23 unselected patients, operated on in June and July of 
1994 (stage I, n : 5; stage II, n = 7; stage IIIA, n = 11), 
We used lung parenchyma for tissue culture. The lung 
pieces were examined histologically (hematoxylin and 
eosin staining), and only tumor-free lung parenchyma (6 
cm distant from the lung cancer) was taken for tissue 
cultures. Three-millimeter squares were washed and incu- 
bated in Hfim's F12 medium and 12% fetal calf serum. 
Every third day a new incubation was done (Hfim's F12 
medium and fetal calf serum). One or two pieces of lung 
parenchyma were selected for histologic (hematoxylin and 
eosin staining) examination. 
Results 
The characteristics of the patients, operations, 
histologic type, and final tumor stage of the patients 
undergoing intraoperative pleural lavage are shown 
in Table I. 
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Fig. 3. Cytologic results in intraoperative pleural avage 
(n = 342 patients). 
Table II. Cytologic results in intraoperative pleural 
lavage according to histology of lung cancer (n = 
342; p = not significanO 
Positive 
Total Negative No. % 
Squamous cell carcinoma 189 113 76 40.2 
Adenocarcinoma 102 59 43 42.1 
Adenosquamous carcinoma 22 12 10 45.5 
Large-cell carcinoma 17 10 7 41.2 
Small-cell carcinoma 12 7 5 41.7 
Control group. No positive results were obtained 
cytologically in any of the 99 patients with nonma- 
lignant disease of the lung; that is, there were no 
false positive findings. 
Study group. Of the 342 patients with lung cancer 
in whom pleural avage was performed, 132 (38.6%) 
had positive results in lavage I (Figs. 1 and 2); 99 of 
them also had positive findings in lavage II. In nine 
patients (2.6%) only lavage II was positive. In most 
of these nine patients in whom only lavage II was 
positive, adhesions of the lung with the parietal 
pleura were found. All 141 patients (41.2%) in 
whom cytologic tumor cell detection was possible 
were assigned to the "positive lavage" group (Fig. 3) 
for the calculations of "stage" and "histologic type." 
To calculate the survivals, we used only the data of 
the 132 patients with a positive lavage I. The nine 
patients with a positive lavage II were excluded from 
the survival analyses, to avoid the effect of any 
possible tumor dissemination by surgery. However, 
Table III. Sites of recurrences for patients 
undergoing intraoperative pleural lavage (subdivided 
in positive and negative lavage i; 43 patients with 
multiple metastases) 
Negative Positive p Value 
All stages (n = 342) 
Local recurrence 12 18 
Distant metastasis 23 78 
Contralateral lung 4 22 
Liver 9 23 
Brain 3 19 
Kidney 5 4 
Suprarenal g and 4 17 
Others 6 33 
Stage I (n = 161) 
Local recurrence 1 3 
Distant metastasis 7 13 
Contralateral lung 1 2 
Liver 2 7 
Brain 2 3 
Kidney 1 i 
Suprarenal gland 0 0 
Others 1 4 
p = 0.69 
p = 0.008 
p = 0.85 
p = 0.039 
the number of patients with a positive lavage II was 
too small to make any statistical analysis. 
Stage. Malignant cells were detected in 47 of 164 
patients with stage I disease (28.6%), 20 of 55 with 
stage II disease (36.4%), 59 of 100 with stage III 
disease (59%), and 15 of 23 with stage IV disease 
(65.2%). Positive findings in intraoperative pleu- 
ral lavage fluid were more frequent in advanced 
tumor stages (p = 0.0001 in stage I versus stages 
II to IV). 
Histology. We found no association between the 
histologic classification of the primary tumor and 
cytologic findings of the intraoperative pleural la- 
vage. The rate of positive results was nearly equal in 
all histologic types (Table II). 
Sites of recurrences. We found a significantly 
higher rate of distant metastases in the patients who 
had a positive pleural lavage I as opposed to those with 
a negative lavage: we found distant metastases in 78 of 
the 132 patients (all stages) with a positive lavage I. Of 
the 201 patients (all stages) with a negative lavage I, 
distant metastases were detected in only 23 (p = 
0.008). In stage I lung cancer we found distant metas- 
tases in 13 of the 47 patients with a positive lavage I
and in seven of the 114 patients with a negative lavage 
[ (p = 0.039) (Table III). 
Prognosis. Median follow-up for all patients was 
46 months. The 4-year survival of patients undergo- 
ing curative resection of non-small-cell lung cancer 
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Fig. 4. Four-year survival of all patients undergoing in- 
traoperative pleural avage, subdivided into "positive lavage" 
(n = 132) and "negative lavage" (n = 201) groups (p = 
0.007). 
was 24% (95% confidence interval, 16% to 32%) if 
lavage I was positive and 52% (95% confidence 
interval, 45% to 59%) if lavage I was negative (all 
stages, p = 0.007) (Fig. 4). If the 4-year survival for 
patients with non-small-cell ung cancer was calcu- 
lated on the basis of positive and negative pleural 
lavage findings, the following results were obtained: 
the cumulative 5-year survival for patients undergo- 
ing curative resection for non-small-cell ung cancer 
in stage I (pT1 NO, pT2 NO) (n = 164) was 29.1% if 
lavage was positive (n = 47) and 69.8% if lavage was 
negative (n = 117) (p = 0.037) (Fig. 5). The 
survivals and 95% confidence intervals of all pa- 
tients are presented in Table IV. 
Multivariate analysis. By multivariate analysis of 
the data on our patients undergoing intraoperative 
pleural lavage, we found that a positive cytologic 
result was an independent risk factor for death 
(relative risk 0.6017; 95% p value 0.0001). Only the 
final tumor stage and the age of the patients were 
also prognostic factors. The relative risk of a poorer 
20, 
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Fig. 5. Four-Year survival of patients undergoing curative 
resection for stage I lung cancer, divided into "positive 
lavage" (n = 47) and "negative lavage" (n = 114) 
groups, if lavage I (before resection) was positive (p - 
0.037). 
prognosis was 1.8252 (95% confidence interval 
1.3430 to 2.4804). 
Lung tissue cultures. In 16 patients (69.6%) we 
detected tumor cells in lung parenchyma between 
the third and thirty-sixth days (median 15 days) after 
incubation. In all patients tumor cells were found in 
lymphatic vessels (Fig. 6). In 14 of these patients the 
intraoperative pleural lavage was also positive 
(87.5%). We found tumor cells in only two lung 
tissue cultures when the pleural lavage of the same 
patient was negative. 
Discussion 
The TNM classification of malignant umors was 
revised in 1992 and a new edition is in progress. The 
pTNM classification of lung cancer is mostly based 
on the histologic examination of the tumor. 6 The 
diagnostic procedures of the pleural cavity are still 
insufficient. Only malignant pleura! effusion is in- 
cluded in the TNM classification as a T4 spread of 
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Fig. 6. Tumor cells (small an'ows) in lung tissue culture in a lymphatic vessel n ar a small pulmonary artery 
and vein (big arrows) 9 days after incubation of tumor-free lung parenchyma of an adenocarcinoma of the 
lung (pT2 NO; hematoxylin and eosin staining, original magnification ×400). 
Table IV. Four-year survivals of 342 patients undergoing intraoperative pleural avage, subdivided into positive 
and negative lavage I (including 95%confidence intervals) 
n lyr 2yr 3yr 4yr 
All 
Positive 132 59 (51 to 67) 36 (28 to 44) 26 (18 to 34) 24 (16 to 32) 
Negative 201 82 (76 to 88) 72 (65 to 79) 61 (53 to 69) 52 (44 to 60) 
p = 0.007 
Stage I
Positive 47 71 (56 to 86) 53 (36 to 70) 36 (19 to 53) 35 (18 to 52) 
Negative 114 87 (79 to 93) 79 (71 to 87) 71 (62 to 80) 69 (60 to 78) 
p = 0.037 
Stage II 
Positive 20 69 (51 to 87) 34 (15 to 53) 28 (11 to 47) 24 (5 to 43) 
Negative 33 85 (71 to 99) 74 (53 to 91) 58 (37 to 79) 48 (23 to 73) 
p = 0.076 
Stage IIIA 
Positive 37 57 (43 to 71) 30 (16 to 44) 18 (5 to 31) 10 (0 to 20) 
Negative 31 77 (62 to 92) 66 (48 to 84) 50 (31 to 69) 36 (17 to 55) 
p = 0.042 
lung cancer. The criterion for malignant pleural 
effusion is the cytologic detection of tumor cells. 6 In 
these patients a curative resection cannot be per- 
formed. 
We present he results of a prospective study, in 
which pleural lavage was done after the chest had 
been opened to determine whether tumor cell dis- 
semination into the pleural cavity had already oc- 
curred in the early stages of lung cancer. A second 
lavage after resection of lung cancer and lymph 
node dissection showed whether surgical manipula- 
tion of the lung parenchyma had led to tumor cell 
contamination of the pleural cavity. 
Cytologic examination of peritoneal lavage fluid 
seems to be an important prognostic factor in ma- 
lignant solid tumors of the abdomen. 12-15 Spjut and 
associates 1 first described the results of cytologic 
examination of pleural cavity washings after pulmo- 
nary resection of lung cancer in 1958; Eagan and 
colleagues 2 followed in 1984. Their reports exam- 
ined only the positive cytologic results of pleural 
lavage after surgical manipulation. The positive 
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findings might occur as a result of the exfoliation 
and contamination of cancer cells into the pleural 
space during surgical manipulation. We must dis- 
criminate between pleural avage performed imme- 
diately after thoracotomy and that performed after 
pulmonary resection. After publication of our pre- 
liminary reports about tumor cell findings in intra- 
operative pleural avage fluid after opening of the 
chest,4, 5 other authors likewise reported etecting 
tumor cells in intraoperative pleural lavage flu- 
id. 16-19 Up  to now we have performed intraoperative 
pleural avage in 342 patients with lung cancer. Our 
recent results emphasize the prognostic significance 
of positive findings of intraoperative pleural avage 
for patients with lung cancer. 
The detection of tumor cells in pleural lavage 
fluid before resection proves that tumor cells have 
spread into the pleural cavity, even in the early 
stages of lung cancer. The pleural cavity in patients 
with positive findings of intraoperative pleural la- 
vage was not contaminated bythe surgical interven- 
tion, because manipulation of the lung and the 
visceral pleura was excluded before the first lavage 
was done. 
How the tumor cells enter the pleural cavity is still 
unknown. We believe that the most likely mode is 
spread via the lymphatic vessels. The results of 
tumor cell detection in lung parenchyma, which 
were initially tumor-free at the beginning of lung 
tissue cultures, could be explained by the tumor cell 
detection in the intraoperative pleural avage fluid. 
In addition, however, it must be a result of exfolia- 
tion of cancer cells and may be possible without any 
pleural effusion. Preformed stomas that connect 
subpleural lymphatics with the pleural space could 
account for the tumor cell dissemination. 2°-25 
The cytologic method of examination of the in- 
traoperative pleural lavage fluid that we used is 
highly specific. We did not find any false positive 
results. We included Papanicolaou class IV and V 
cytologic results in our "positive lavage" group. This 
might explain why we had a higher percentage of 
positive cytologic findings in pleural lavage than 
other authors. 2'3. 16-19 In most of the other studies, 
positive results in squamous cell carcinoma were not 
as high as in our study. 
The positive findings of pleural lavage are a 
significant prognostic factor for patients with lung 
cancer. Our recent results with 342 patients who had 
tung cancer confirm our first results with 59 patients. 
We found a significantly poorer 4-year survival if 
tumor cell detection was possible. The survival was 
35% in stage I lung cancer if we found tumor cells in 
the lavage fluid and 69% if the result was negative. 
In our small group of patients with stage II disease 
the difference was not significant, but in stage IIIA 
the survival was statistically significantly worse if the 
results of pleural avage were positive. In a multi- 
variate analysis, a positive cytology of pleural avage 
was an additional prognostic factor for patients with 
lung cancer. 
Therefore, cytologic examination of intraopera- 
tire pleural lavage fluid should be done when assess- 
ing the final tumor stage in patients with lung 
cancer. A positive result should be added to the 
pTNM classification. In view of these findings, we 
have started a new randomized study of adjuvant 
chemotherapy for those patients with a positive 
cytology of intraoperative pleural avage in stage I
lung cancer. 
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Discussion 
Dr. Walter B. Cannon (Palo Alto, Calif.). This paper 
compares the differences between pathologic stage of 
disease versus clinical stage. As Dr. Buhr has said, the 
most important patients that they are dealing with are 
those with stage I disease--patients who are thought o 
have been cured because the tumor is out and because 
lymph nodes are not involved. He, however, has found 
that in numerous patients there is a significant involve- 
ment of the pleural cavity by tumor cells. The practice of 
evaluating cytologic haracteristics of fluid within a cavity 
has long been in effect in the treatment of ovarian cancer. 
Peritoneal lavages looking at the fluid after the procedure 
have altered dramatically how these patients are treated 
and certainly has altered the prognosis--from a 70% 
4-year survival to a 35% 4-year survival if the pleural 
cavity is contaminated by tumor cells. The issue that I 
raise here concerns the situation in which the recurrences 
of these tumors occur in patients with only pleural in- 
volvement. Is the recurrence in the pleura or is it systemic 
recurrence7 If it is a pleural recurrence, should local 
treatment factors be taken into account at the time of an 
operation, such as installation ofchemotherapeutic agents 
within the pteural cavity or possibly even installation of 
sterile water into the pleural cavity? Can you answer these 
questions for us. Dr. Buhr? 
Dr. Buhr. We found that local recurrence is no more 
common in patients with a positive result on pleural 
lavage than in those with a negative result. Those patients 
died with metastases, sowe think this was only a sign that 
tumor had spread in the whole body, not only in the chest. 
We use systemic hemotherapy for patients who have 
metastases. We do not instill any chemotherapy or water 
in the pleural cavity after the resection. 
Dr. Cannon. Why are these patients with apparent T4 
disease having as high as a 35% 4-year survival compared 
with those patients who would have pleural fluid with 
positive cytology, who would have a lesser 4-year survival? 
Dr. Buhr. I do not think the positive cytologic findings 
in pleural lavage fluid indicate T4 spread of the lung 
cancer. As you know. in ovarian cancer the lavage is 
included in TNM classification and is included as a suffix 
to the histologic stage of the tumor. I think that if the 
result and the procedure are added to the TNM classifi- 
cation it must be the same: we have to add the result as a 
suffix to the T classification of the tumor because survival 
is not as poor in the patient with a positive cytologic result 
as in a patient with a malignant pleural effusion. 
Dr. Cannon. When looking for malignant cells within 
the tumor-free parenchyma of the lung, did you look only 
in the lobe that had been removed or did you ever look in 
an adjacent lobe? If se, was there violation across the 
fissure rather than just direct lymphatic extension within 
the lobe that you had taken out? 
Dr. Buhr. We do the lung parenchyma tissue cultures 
from the same lobe and not from the other lobe. But the 
study- with our lung tissue cultures was too small to find 
any statistical differences. 
Dr. Alan S. Coulson ,'Stockton. Calif.). I remember 
years ago we used to culture cancer cells with tymphocytes 
to see if the body's immune system would somehow attack 
the cells in culture. It seems to me you have a perfect 
model here if you could take some white cells or lympho- 
cytes from the patient and culture the cancer cells with the 
white cells through 3 or 4 days to see whether there is a 
reaction that would be predictive of patient survival. 
Dr. Buhr. I think the study with the lung tissue cultures 
is too small to allow any other examples or explanations. 
I do not believe we find new tumor cells. We find dormant 
tumor cells in the lung that we have not detected earlier 
with normal histologic studies, and we detect hose tumor 
cells after incubation and tissue culture. And thank you 
for your comment. We will try this study with lymphocytes 
and lung tissue cultures in the future. 
